Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves
- D.C. United’s Danita Johnson Becomes First Woman To Join Buzzer’s Board Of Directors also categorized in BoardMoves
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
- Why Do Board Directors And CEOs Need To Value UN Sustainability Goal 5 ? - Achieve Gender Equality And Empower All Women And Girls also categorized in BoardMoves
Login to comment.